World's 1st trial deliberating infecting young adults with COVID found to be safe
No serious adverse events occurred, the company said
Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No serious adverse events occurred, the company said
Open Orphan is running the project, launched a year ago, with Imperial College London, UK govt's vaccines task force and hVIVO.
Scientists at Open Orphan (ORPH.L) have published results from the "world’s first" trial in which volunteers were deliberately exposed to COVID.
The trial infected 36 healthy male and female volunteers aged 18-29 years with the original SARS-CoV-2 strain of the virus and closely monitored them in a controlled quarantined setting.
Open Orphan test shows shorter incubation period, effectiveness of lateral flow tests